Leflunomide 20 mg tablets (geneva pharmaceutical) (DrugBank: Leflunomide)
10 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
11 | 重症筋無力症 | 0 |
40 | 高安動脈炎 | 0 |
46 | 悪性関節リウマチ | 1 |
49 | 全身性エリテマトーデス | 0 |
53 | シェーグレン症候群 | 0 |
66 | IgA腎症 | 0 |
162 | 類天疱瘡(後天性表皮水疱症を含む。) | 0 |
224 | 紫斑病性腎炎 | 0 |
271 | 強直性脊椎炎 | 0 |
300 | IgG4関連疾患 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00946686 (ClinicalTrials.gov) | September 2002 | 24/7/2009 | To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions | A Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions | Rheumatoid Arthritis;Psoriatic Arthritis | Drug: Leflunomide 20 mg Tablets (Geneva Pharmaceutical);Drug: Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.) | Sandoz | NULL | Completed | 18 Years | N/A | All | 52 | Phase 1 | NULL |